| Specialty Retail Industry | Consumer Discretionary Sector | Wan-Kap Park CEO | KRX SM Exchange | KR7063160006 ISIN |
| KR Country | 519 Employees | 27 Dec 2024 Last Dividend | 27 Dec 2019 Last Split | - IPO Date |
CKD Bio Corp. is a multifaceted company primarily known for its significant contribution to the pharmaceutical industry. Founded in 1941 and based in Seoul, South Korea, the company has expanded its reach beyond its home country, establishing a presence in Europe, Asia, the Middle East, and other international markets. While the core of its business revolves around the manufacturing and sale of pharmaceutical products, CKD Bio Corp. has diversified its operations to include real estate leasing, cosmetic and health functional food productions, property management, advertising communication, and IT consulting, construction, and maintenance. By exporting its products, the company has solidified its position on the global stage, reflecting its commitment to improving health and quality of life around the world.
CKD Bio Corp. offers a broad range of products and services, catering to different sectors including healthcare, real estate, IT, and more. Below is an overview of its primary offerings: